2-Development of a novel bivalent vaccine candidate against hepatitis A virus and rotavirus using reverse vaccinology and immunoinformatics-Journal of Virus Eradication/Volume 11, Issue 1, March 2025, 100578
3-Study on the correlation between DPP9 rs2109069 and IFNAR2 rs2236757 polymorphisms with COVID-19 mortality -/Nucleosides Nucleotides Nucleic Acids 2025;44(1):41-56doi: 10.1080/15257770.2024.2344179. Epub 2024 Apr 25
4-Inhibition of HIV-1 infection with curcumin conjugated PEG-citrate dendrimer; a new nano formulation /BMC Complement Med The /2024 Oct 2;24(1):350.doi: 10.1186/s12906-024-04634-8/https://pmc.ncbi.nlm.nih.gov/articles/PMC11448447
5-Reverse Vaccinology and Immunoinformatic Approach for Designing a Bivalent Vaccine Candidate Against Hepatitis A and Hepatitis B Viruses / 2024 Sep;66(9):2362-2380 doi: 10.1007/s12033-023-00867-z. Epub 2023 Sep 16.
6-Engineered ClearColi™-derived outer membrane vesicles as functional carriers for development of HIV-1 therapeutic vaccine candidate /SCIENCE DIRECT/Volume 10, Issue 15, 15 August 2024, e35124
10-Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial /Frontires in immunology/Volume 15 - 2024 /
13-Determining buffer conditions for downstream processing of VLP-based recombinant hepatitis B surface antigen using multimodal resins in bind-elute and flow-through purification modes/nature/2023/https://www.nature.com/articles/s41598-023-37614-y
14-Signal amplification of a quartz crystal microbalance immunosensor by gold nanoparticles-polyethyleneimine for hepatitis B biomarker detection/nature/2023/https://www.nature.com/articles/s41598-023-48766-2
18-Impact of TRIM5α and TRIM22 Genes Expression on the Clinical Course of Coronavirus Disease/Art Med Res/2023 Feb;54(2):105-112.doi: 10.1016/j.arcmed.2022.12.010. Epub 2022 Dec 28/https://pmc.ncbi.nlm.nih.gov/articles/PMC9794484/
20-Evaluation of miR-let-7f, miR-125a, and miR-125b expression levels in sputum and serum samples of Iranians and Afghans with pulmonary tuberculosis/Iran J Microbial/https://pmc.ncbi.nlm.nih.gov/articles/PMC10628080/
21-Immunogenicity evaluation of a novel virus-like particle vaccine candidate against SARS-CoV-2 in BALB/c/Patog Dis ,2023 Jan 17:81:ftad021.
29-The association between interferon lambda 3 and 4 gene single-nucleotide polymorphisms and the recovery of COVID-19 patients/Virol J/2021 Nov 14;18(1):221 /https://pmc.ncbi.nlm.nih.gov/articles/PMC8590865/
30-Lamivudine-conjugated and efavirenz-loaded G2 dendrimers: Novel anti-retroviral nano drug delivery systems/IET Biotechnal/2021 Jun 10;15(7):627–637. /https://pmc.ncbi.nlm.nih.gov/articles/PMC8675833/
31-Changes in the Distribution Pattern of Hepatitis C Virus Genotypes Among Chronic Hepatitis Patients: a Cross-Sectional Study/Clin Lab/2021 Aug 1;67(8) /https://www.clin-lab-publications.com/article/3849
36-Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis/Plos One/2020 Oct 15;15(10):e0240577/https://pmc.ncbi.nlm.nih.gov/articles/PMC7561160/
37-No evidence of occult HBV infection in population born after mass vaccination/2020 Jun;170(9-10):218-223 /
47-Application of recurrent neural network for online prediction of cell density of recombinant Pichia pastoris producing HBsAg/. 2019;49(4):352-359. /https://pubmed.ncbi.nlm.nih.gov/30707051/
49-Synthesis, Molecular Modelling and Biological Studies of 3-hydroxypyrane- 4-one and 3-hydroxy-pyridine-4-one Derivatives as HIV-1 Integrase Inhibitors/2019;15(7):755-770/https://www.eurekaselect.com/article/95316
50-Design, Synthesis, Docking Studies and Biological Activities Novel 2,3- Diaryl-4-Quinazolinone Derivatives as Anti-HIV-1 Agents/ 2019;17(3):214-222/https://www.eurekaselect.com/article/100735
دکتر سید مهدی سادات
1-Novel bioinformatics approaches to design epitope-based vaccine against HIV latency by inquiring CTL epitopes and built-in adjuvants/Article number: 32809 (2025) /
4-The Combinatorial Effect of Ad-IL-24 and Ad-HSV-tk/GCV on Tumor Size, Autophagy, and UPR Mechanisms in Multiple Myeloma Mouse Model/2025 Feb;63(1):315-330.doi: 10.1007/s10528-024-10671-2. Epub 2024 Mar 4./https://link.springer.com/article/10.1007/s10528-024-10671-2
6-Retraction notice to "Development of novel HPV therapeutic vaccine constructs based on engineered exosomes and tumor cell lysates" [Life Sci. 340 (2024) 122456]/ 2024 Aug 15:351:122831./doi: 10.1016/j.lfs.2024.122831. Epub 2024 Jun 12./
7-Development of novel HPV therapeutic vaccine constructs based on engineered exosomes and tumor cell lysates/ 2024 Mar 1:340:122456.doi: 10.1016/j.lfs.2024.122456. Epub 2024 Jan 23/https://pubmed.ncbi.nlm.nih.gov/38266814/
8-In silico designing of novel epitope-based peptide vaccines against HIV-1/ 2024 Jun;46(3):315-354.doi: 10.1007/s10529-023-03464-x. Epub 2024 Feb 26./https://pubmed.ncbi.nlm.nih.gov/38403788/
9-Comparative Analysis of IMT-P8 and LDP12 Cell-Penetrating Peptides in Increasing Immunostimulatory Properties of HIV-1 Nef-MPER-V3 Antigen/ 2024;31(10):818-826.doi: 10.2174/0109298665337811241010104557. /https://pubmed.ncbi.nlm.nih.gov/39558498/
10-Alum and a TLR7 agonist combined with built-in TLR4 and 5 agonists synergistically enhance immune responses against HPV RG1 epitope/Article number: 16801 (2023) /https://www.nature.com/articles/s41598-023-43965-3
11-Immunogenicity evaluation of a novel virus-like particle vaccine candidate against SARS-CoV-2 in BALB/c/ 2023 Jan 17:81:ftad021.doi: 10.1093/femspd/ftad021/DOI: 10.1093/femspd/ftad021/https://pubmed.ncbi.nlm.nih.gov/37667486/https://pubmed.ncbi.nlm.nih.gov/37667486/
13-Expression and characterization of two dna constructs derived from hiv-1-vif in escherichia coli and mammalian cells/2021 Jul-Sep;13(3):131-135.doi: 10.18502/ajmb.v13i3.6369. /https://pubmed.ncbi.nlm.nih.gov/34484642/
14-HIV-1 p24-nef DNA Vaccine Plus Protein Boost Expands T-Cell Responses in BALB/c/2021;18(7):1014-1021.doi: 10.2174/1567201818666210101113601/https://pubmed.ncbi.nlm.nih.gov/33388019/
15-Evaluation of transduced dendritic cells expressing HIV-1 p24-Nef antigens in HIV-specific cytotoxic T cells induction as a therapeutic candidate vaccine 2021 Jun:298:198403.doi: 10.1016/j.virusres.2021.198403. Epub 2021 Mar 26/https://pubmed.ncbi.nlm.nih.gov/33775753/
16-Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19/ 2021 May;63(5):389-409.doi: 10.1007/s12033-021-00303-0. Epub 2021 Feb 24./https://pubmed.ncbi.nlm.nih.gov/33625681/
19-Production of Recombinant HIV-1 p24-Nef Protein in Two Forms as Potential Candidate Vaccines in Three Vehicles/ 2020;17(5):387-395.doi: 10.2174/1567201817666200317121728. /https://www.eurekaselect.com/article/105307
20-Effective Delivery of Nef-MPER-V3 Fusion Protein Using LDP12 Cell Penetrating Peptide for Development of Preventive/Therapeutic HIV-1 Vaccine/ 2020;27(11):1151-1158.doi: 10.2174/0929866527666200504121400./https://www.eurekaselect.com/article/106340
21-Production and Evaluation of the Properties of HIV-1-Nef-MPER-V3 Fusion Protein Harboring IMT-P8 Cell Penetrating Peptide/ 2020;18(5):315-323.doi: 10.2174/1570162X18666200612151925. /https://www.eurekaselect.com/article/107308
22-Production and Evaluation of the Properties of HIV-1-Nef-MPER-V3 Fusion Protein Harboring IMT-P8 Cell Penetrating Peptide// 2020;18(5):315-323.doi: 10.2174/1570162X18666200612151925. /https://www.eurekaselect.com/article/107308
24-Design and in vitro delivery of HIV-1 multi-epitope DNA and peptide constructs using novel cell-penetrating peptides/ 2019 Nov;41(11):1283-1298 doi: 10.1007/s10529-019-02734-x. Epub 2019 Sep 17./https://link.springer.com/article/10.1007/s10529-019-02734-x
28-Truncated Core/NS3 Fusion Protein of HCV Adjuvanted with Outer Membrane Vesicles of Neisseria meningitidis Serogroup B: Potent Inducer of the Murine Immune System/ 2019 Jul;23(4):235-45 doi: 10.29252/.23.4.235. Epub 2018 Oct 3./https://pmc.ncbi.nlm.nih.gov/articles/PMC6462289/
29-Induction of a Robust Humoral Response using HIV-1 VLPMPER-V3 as a Novel Candidate Vaccine in BALB/c Mice/2019;17(1):33-41.doi: 10.2174/1570162X17666190306124218. /https://pubmed.ncbi.nlm.nih.gov/30843489/
30-Delivery of HIV-1 Polyepitope Constructs Using Cationic and Amphipathic Cell Penetrating Peptides into Mammalian Cells/2019;17(6):408-428doi: 10.2174/1570162X17666191121114522. /https://pubmed.ncbi.nlm.nih.gov/31755394/
31-The distinct role of small heat shock protein 20 on HCV NS3 expression in HEK-293T cell line/2018 Jul-Sep;10(3):152-157. /https://pubmed.ncbi.nlm.nih.gov/30090208/
32-Design, Synthesis, and Anti-HIV-1 Evaluation of a Novel Series of 1,2,3,4-Tetrahydropyrimidine-5-Carboxylic Acid Derivatives/2018
33-In Silico Design and Immunologic Evaluation of HIV-1 p24-Nef Fusion Protein to Approach a Therapeutic Vaccine Candidate/ 2018 Oct 1;64(10):1641-1647.doi: 10.7754/Clin.Lab.2018.180406. /https://www.clin-lab-publications.com/article/2857
41-The Efficiency of Tat Cell Penetrating Peptide for Intracellular Uptake of HIV-1 Nef Expressed in E. coli and Mammalian Cell/ 2017;14(4):536-542.doi: 10.2174/1567201813666161006114448. /https://www.eurekaselect.com/article/78786
42-Delivery of HIV-1 Nef Protein in Mammalian Cells Using Cell Penetrating Peptides as a Candidate Therapeutic Vaccine/
44-IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C/ 2017 Jan;162(1):181-189. doi: 10.1007/s00705-016-3095-1. Epub 2016 Oct 6./https://link.springer.com/article/10.1007/s00705-016-3095-1
45-From in-silico immunogenicity verification to in vitro expression of recombinant Core-NS3 fusion protein of HCV/
47-Interleukin 20 Gene Polymorphism (rs1518108) is not Associated with Sustained Virological Response in Iranian Patients with Hepatitis C Virus Infection/
48-Expression of HCV Alternative Reading Frame Protein (Core+1/F) in Baculovirus Expression System and its Evaluation for Assessment of Specific Anti-core+1 Antibody in Iranian HCV Infected Patients/ 2016 Oct 1;62(10):1919-1926. doi: 10.7754/Clin.Lab.2016.160205./https://www.clin-lab-publications.com/article/2271
2-Study on the correlation between DPP9 rs2109069 and IFNAR2 rs2236757 polymorphisms with COVID-19 mortality/2025;44(1):41-56.doi: 10.1080/15257770.2024.2344179. Epub 2024 Apr 25./https://pubmed.ncbi.nlm.nih.gov/38660988/
4-Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial/2024 Apr 8:15:1332425.doi: 10.3389/fimmu.2024.1332425. eCollection 2024./https://pmc.ncbi.nlm.nih.gov/articles/PMC11036872/
7-Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19/ 2023 Jun;18(9):563-574doi: 10.2217/fvl-2022-0210. Epub 2023 Jul 13./https://pmc.ncbi.nlm.nih.gov/articles/PMC10348059/
8-Impact of TRIM5α and TRIM22 Genes Expression on the Clinical Course of Coronavirus Disease 2019/2023 Feb;54(2):105-112. doi: 10.1016/j.arcmed.2022.12.010. Epub 2022 Dec 28./https://pmc.ncbi.nlm.nih.gov/articles/PMC9794484/
9-Comparing the expression levels of tripartite motif containing 28 in mild and severe COVID-19 infection/ 2022 Oct 3;19(1):156.doi: 10.1186/s12985-022-01885-0. /https://pmc.ncbi.nlm.nih.gov/articles/PMC9527726/
10-Correction: comparing the expression levels of tripartite motif containing 28 in mild and severe COVID-19 infection/ 2022 Oct 31;19(1):171. doi: 10.1186/s12985-022-01903-1./https://pmc.ncbi.nlm.nih.gov/articles/PMC9624030/
11-Development of a T Cell-targeted siRNA Delivery System Against HIV-1 Using Modified Superparamagnetic Iron Oxide Nanoparticles: An In Vitro Study/
2022 May;111(5):1463-1469. doi: 10.1016/j.xphs.2021.10.018. Epub 2021 Oct 19./
12-The association between interferon lambda 3 and 4 gene single-nucleotide polymorphisms and the recovery of COVID-19 patients/ 2021 Nov 14;18(1):221.doi: 10.1186/s12985-021-01692-z. /https://pmc.ncbi.nlm.nih.gov/articles/PMC8590865/
13-Lamivudine-conjugated and efavirenz-loaded G2 dendrimers: Novel anti-retroviral nano drug delivery systems/ 2021 Sep;15(7):627-637.doi: 10.1049/nbt2.12060. Epub 2021 Jun 10./https://pmc.ncbi.nlm.nih.gov/articles/PMC8675833/
14-Prevalence of Naturally-Occurring NS5A and NS5B Resistance-Associated Substitutions in Iranian Patients With Chronic Hepatitis C Infection/
21-Molecular Approach for HIV-1 Replication Inhibition: Assessment of Different siRNAs Targeting Tat and Nef Genes to Effectively Suppress their ExpressioN/
22-Rabies Prophylaxis Strategy in Iran, a Need for an Alternative Strategy: Would the Essen Regimen be Replaced by Zagreb Protocol?/2019 Jan 1;65(1).doi: 10.7754/Clin.Lab.2018.180619. /https://www.clin-lab-publications.com/article/2902
24-Truncated JFH1 E2 Protein: Is it Reliable to be Used in Diagnostic ELISA Test and as a Protein-Based Vaccine Candidate؟/ 2018 Feb 8;24(12):1179-1184.doi: 10.2174/0929866524666171009164314. /https://www.eurekaselect.com/article/86285
26-Expression of HCV Alternative Reading Frame Protein (Core+1/F) in Baculovirus Expression System and its Evaluation for Assessment of Specific Anti-core+1 Antibody in Iranian HCV Infected Patients 2016 Oct 1;62(10):1919-1926.doi: 10.7754/Clin.Lab.2016.160205. /https://www.clin-lab-publications.com/article/2271
29-Impact of TGF-β1 Gene Polymorphism (rs1800469) on Treatment Response to Pegylated Interferon/Ribavirin in Iranian Patients with Hepatitis C/ 2016;62(4):609-14.doi:10.7754/clin.lab.2015.150807./https://pubmed.ncbi.nlm.nih.gov/27215079/
30-Evaluation of truncated HCV-NS3 protein for potential applications in immunization and diagnosis/
31-Impact of human enterovirus 71 genotypes in meningoencephalitis in Iran/Jundishapur J Microbiol . 2015 Dec 26;8(12):e27113. doi: 10.5812/jjm.27113. eCollection 2015 Dec./https://pmc.ncbi.nlm.nih.gov/articles/PMC4744466/
3-Alterations of the gut microbiota in patients with diabetic nephropathy and its association with the renin-angiotensin system/2025 Feb 20;24(1):69. doi: 10.1007/s40200-025-01579-8. eCollection 2025 Jun.
5-In silico design of a trivalent multi-epitope global-coverage vaccine-candidate protein against influenza viruses: evaluation by molecular dynamics and immune system simulation/ 2025 Feb;43(3):1522-1538.doi: 10.1080/07391102.2023.2292293. Epub 2023 Dec 13./https://pubmed.ncbi.nlm.nih.gov/38088331/
7-Reverse Vaccinology and Immunoinformatic Approach for Designing a Bivalent Vaccine Candidate Against Hepatitis A and Hepatitis B Viruses/ 2024 Sep;66(9):2362-2380. doi: 10.1007/s12033-023-00867-z. Epub 2023 Sep 16./https://link.springer.com/article/10.1007/s12033-023-00867-z
10-Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies/2024 Jun;16(3):796-814. doi: 10.1007/s12602-023-10070-w. Epub 2023 May 6.PMID: 37148452DOI: 10.1007/s12602-023-10070-w
11-Investigating the Effects of HMGB1 Overexpression on Colorectal Cancer Cell Migration via Oncolytic Herpes simplex Virus Type 1 (oHSV-1)/
13-Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial/ 2024 Apr 8:15:1332425.doi: 10.3389/fimmu.2024.1332425. eCollection 2024./https://pmc.ncbi.nlm.nih.gov/articles/PMC11036872/
14-An Overview on the Pathophysiological Roles of microRNA-802: a Literature Review/April 2023Biointerface Research in Applied Chemistry13(2)DOI: 10.33263/BRIAC132.17/https://www.researchgate.net/publication/370047546_An_Overview_on_the_Pathophysiological_Roles_of_microRNA-802_a_Literature_Review
15-In silico Identification of Hypoxic Signature followed by reverse transcription-quantitative PCR Validation in Cancer Cell Lines/ 2023 Jan 1;27(1):23-33. doi: 10.52547/ibj.3803./https://pmc.ncbi.nlm.nih.gov/articles/PMC9971715/
17-Characterization of gut microbiota profile in Iranian patients with bipolar disorder compared to healthy controls/2023 Sep 21:13:1233687.doi: 10.3389/fcimb.2023.1233687. eCollection 2023./https://pmc.ncbi.nlm.nih.gov/articles/PMC10552146/
19-Cell type-specific response of colon cancer tumor cell lines to oncolytic HSV-1 virotherapy in hypoxia/2022 Apr 27;22(1):164. doi: 10.1186/s12935-022-02564-4./https://pmc.ncbi.nlm.nih.gov/articles/PMC9044800/
20-The global scientific publications on gut microbiota in type 2 diabetes; a bibliometric, Scientometric, and descriptive analysis/2021 Nov 18;21(1):13-32.doi: 10.1007/s40200-021-00920-1. eCollection 2022 Jun./https://pmc.ncbi.nlm.nih.gov/articles/PMC9167415/
21-RNA Expression Analysis of Mycobacterial Methyltransferases Genes in Different Resistant Strains of Mycobacterium tuberculosis/ 2022 May
22-Differential gene expression of BCL-2, ZEB2-AS1 and BALR-2 in prostate cancer and benign prostatic hyperplasia/2022 Apr;54(3):e14344. doi: 10.1111/and.14344. Epub 2021 Dec 5./https://onlinelibrary.wiley.com/doi/10.1111/and.14344
23-Bioinformatic Investigation of Micro RNA-802 Target Genes, Protein Networks, and Its Potential Prognostic Value in Breast Cancer/ 2022 Apr-Jun;14(2):154-164.doi: 10.18502/ajmb.v14i2.8882. /https://pmc.ncbi.nlm.nih.gov/articles/PMC9077654/
24-Immunoinformatics Evaluation of a Fusion Protein Composed of Leishmania infantum LiHyV and Phlebotomus kandelakii Apyrase as a Vaccine Candidate against Visceral Leishmaniasis/ 2022 Apr-Jun;17(2):145-158. doi: 10.18502/ijpa.v17i2.9530./https://pmc.ncbi.nlm.nih.gov/articles/PMC9363246/
25-Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19/ 2021 May;63(5):389-409.doi: 10.1007/s12033-021-00303-0. Epub 2021 Feb 24./https://pmc.ncbi.nlm.nih.gov/articles/PMC7902242/
26-Prevalence of Naturally-Occurring NS5A and NS5B Resistance-Associated Substitutions in Iranian Patients With Chronic Hepatitis C Infection/ 2021 Jan 28:11:617375. doi: 10.3389/fmicb.2020.617375. eCollection 2020./https://pmc.ncbi.nlm.nih.gov/articles/PMC7876467/
27-Full-length Sequencing and Genotyping of Hepatitis A Virus among Acute Hepatic Patients in Iran/ 2021 May 1;67(5).doi: 10.7754/Clin.Lab.2020.200919. /https://www.clin-lab-publications.com/article/3764
28-Impact of the gut microbiota on vaccine responses/2025 Dec;17(1):2549585.doi: 10.1080/19490976.2025.2549585. Epub 2025 Aug 30./
30-The regulation of Niemann-Pick C1-Like 1 (NPC1L1) gene expression in opposite direction by Bacteroides spp. and related outer membrane vesicles in Caco-2 cell line/ 2020 Apr 22;19(1):415-422.doi: 10.1007/s40200-020-00522-3. eCollection 2020 Jun.https://pmc.ncbi.nlm.nih.gov/articles/PMC7270389/
31-Pulmonary Infection Associated with Mycobacterium canariasense in Suspected Tuberculosis Patient, Iran/2019 Oct;25(10):1984-1986. doi: 10.3201/eid2510.190156./https://pmc.ncbi.nlm.nih.gov/articles/PMC6759235/
32-Rabies Prophylaxis Strategy in Iran, a Need for an Alternative Strategy: Would the Essen Regimen be Replaced by Zagreb Protocol?2019 Jan 1;65(1).
33-In Silico Design and Immunologic Evaluation of HIV-1 p24-Nef Fusion Protein to Approach a Therapeutic Vaccine Candidate/ 2018;16(5):322-337.doi: 10.2174/1570162X17666190102151717. /https://pmc.ncbi.nlm.nih.gov/articles/PMC6446525/
5-Investigation of the Potency of KALA and REV Cell-Penetrating Peptides for In Vitro/In Vivo Delivery of an HPV Multiepitope DNA Construct/2025 Mar;31(3):e70000. doi: 10.1002/psc.70000./https://pubmed.ncbi.nlm.nih.gov/39853698/
7-Editorial: The global phenotypic diversity of HIV-1: implications for pathogenesis, vaccine, and cure/ 2025 Feb 28:16:1572732.doi: 10.3389/fimmu.2025.1572732. eCollection 2025./https://pmc.ncbi.nlm.nih.gov/articles/PMC11906715/
9-Genotyping R1336X and Eliminating the Pseudogene Amplification in Type 3 von Willebrand Disease Patients/2025 Jan;41(1):121-126.doi: 10.1007/s12288-024-01798-8. Epub 2024 Jun 24./https://pubmed.ncbi.nlm.nih.gov/39917504/
10-Unveiling the Immunostimulatory Potential of the HSPA1A Mini-Chaperones Compared to the HSPA1A and HSP27 Chaperones: In Silico and In Vitro Insights for Vaccine Development/ 2025 Oct;44(5):611-638.doi: 10.1007/s10930-025-10285-6. Epub 2025 Aug 14./https://link.springer.com/article/10.1007/s10930-025-10285-6
11-Effective Plant-Derived Proteins and Peptides in Leukemia Treatment/2025 Sep 10.doi: 10.2174/0109298665395842250814085828. Online ahead of print./https://www.eurekaselect.com/article/150503
12-Peptide-Membrane Docking and Molecular Dynamic Simulation of In Silico Detected Antimicrobial Peptides from Portulaca oleracea's Transcriptome/2024 Oct;16(5):1501-1515.doi: 10.1007/s12602-024-10261-z. Epub 2024 May 4./https://link.springer.com/article/10.1007/s12602-024-10261-z
13-Erratum: Advances in cell-based delivery of oncolytic viruses as therapy for lung cancer (Molecular Therapy: Oncology (2024) 32(1), (S2950329924000304), (10.1016/j.omton.2024.200788))/ 2024 Jul 23;32(3):200848. doi: 10.1016/j.omton.2024.200848. eCollection 2024 Sep 19./https://pmc.ncbi.nlm.nih.gov/articles/PMC11318537/
14-The role of T regulatory cells in the immunopathogenesis of HIV: Clinical implications/ 2024 Sep-Oct;28(5):103866. doi: 10.1016/j.bjid.2024.103866. Epub 2024 Aug 18./https://pmc.ncbi.nlm.nih.gov/articles/PMC11402453/
17-Engineered dendritic cells-derived exosomes harboring HIV-1 Nefmut-Tat fusion protein and heat shock protein 70: A promising HIV-1 safe vaccine candidate/
2024 Jun;270(Pt 2):132236 doi: 10.1016/j.ijbiomac.2024.132236. Epub 2024 May 18./
18-Advances in cell-based delivery of oncolytic viruses as therapy for lung cancer/2024 Feb 29;32(1):200788.doi: 10.1016/j.omton.2024.200788. eCollection 2024 Mar 21./https://pmc.ncbi.nlm.nih.gov/articles/PMC10976516/
20-Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel HIV-1 vaccine formulations/ 2024 Feb;25(2):276-290.doi: 10.1111/hiv.13576. Epub 2023 Nov 7./https://onlinelibrary.wiley.com/doi/10.1111/hiv.13576
21-Pivotal Role of miRNA–lncRNA Interactions in Human Diseases// 2024 Dec 13.doi: 10.1007/s12033-024-01343-y. Online ahead of print./
22-Heterologous DNA Prime/Protein Boost Immunization Targeting Nef-Tat Fusion Antigen Induces Potent T-cell Activity and in vitro Anti-SCR HIV-1 Effects/ 2024;22(2):109-119.doi: 10.2174/011570162X297602240430142231. /https://www.eurekaselect.com/article/140212
23-Investigation of Immunostimulatory Effects of IFN-γ Cytokine and CD40 Ligand Costimulatory Molecule for Development of HIV-1 Therapeutic Vaccine Candidate
25-Comparative Analysis of IMT-P8 and LDP12 Cell-Penetrating Peptides in Increasing Immunostimulatory Properties of HIV-1 Nef-MPER-V3 Antigen/2024;31(10):818-826.doi: 10.2174/0109298665337811241010104557. /https://www.eurekaselect.com/article/144550
29-Application of Cell Penetrating Peptides as a Promising Drug Carrier to Combat Viral Infections/ 2023 Sep;65(9):1387-1402.doi: 10.1007/s12033-023-00679-1. Epub 2023 Jan 31./https://pmc.ncbi.nlm.nih.gov/articles/PMC9888354/
30-Immunoinformatics studies of heat shock proteins 27 and 70: Development of potent therapeutic vaccine constructs against human papillomavirus-related cancers/
32-Lipid-Based Delivery Systems in Development of Genetic and Subunit Vaccines/ 2023 May;65(5):669-698. doi: 10.1007/s12033-022-00624-8. Epub 2022 Dec 3./https://pmc.ncbi.nlm.nih.gov/articles/PMC9734811/
33-Extracellular vesicles in vaccine development and therapeutic approaches for viral diseases /Process Biochemistry/Volume 128, May 2023, Pages 167-180/
36-LL-37 antimicrobial peptide and heterologous prime-boost vaccination regimen significantly induce HIV-1 Nef-Vpr antigen- and virion-specific immune responses in mice/2023 Jan;45(1):33-45.doi: 10.1007/s10529-022-03339-7. Epub 2022 Dec 22./https://link.springer.com/article/10.1007/s10529-022-03339-7
37-Comparison of Adjuvant Effects of Montanide ISA-720 and Heat Shock Protein 27 in Increasing Immunostimulatory Properties of HIV-1 Nef-Vif Fusion Protein Construct/ 2023;30(5):401-410.doi: 10.2174/0929866530666230403093538./https://www.eurekaselect.com/article/130648
38-Antiviral Peptides Derived from Plants: Their Designs and Functions/ 2023;30(12):975-985.doi: 10.2174/0109298665278148231106052509. /https://www.eurekaselect.com/article/136324
41-In vitro Delivery of HIV-1 Nef-Vpr DNA Construct Using the Human Antimicrobial Peptide LL-37/ 2022;19(10):1083-1092./doi: 10.2174/1567201819666220217164055. /https://www.eurekaselect.com/article/120994
42-Cell penetrating peptide: A potent delivery system in vaccine development/2022 Nov 8:13:1072685./ doi: 10.3389/fphar.2022.1072685. eCollection 2022./https://pmc.ncbi.nlm.nih.gov/articles/PMC9679422/
43-Current and future direction in treatment of HPV-related cervical disease/ 2022 Jun;100(6):829-845.doi: 10.1007/s00109-022-02199-y. Epub 2022 Apr 27./https://pmc.ncbi.nlm.nih.gov/articles/PMC9045016/
45-Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen/2022 Jun 9;17(6):e0268251. doi: 10.1371/journal.pone.0268251. eCollection 2022./https://pmc.ncbi.nlm.nih.gov/articles/PMC9182696/
46-Gene delivery in adherent and suspension cells using the combined physical methods/ 2022 Apr;74(2):245-257. doi: 10.1007/s10616-022-00524-4. Epub 2022 Feb 3./https://pmc.ncbi.nlm.nih.gov/articles/PMC8975990/
48-Comparison of the Efficacy of HIV-1 Nef-Tat-Gp160-p24 Polyepitope Vaccine Candidate with Nef Protein in Different Immunization Strategies/ 2022;19(1):142-156.doi: 10.2174/1567201818666210224101144. https://www.eurekaselect.com/article/114496
51-Immunopotentiation by linking Hsp70 T-cell epitopes to Gag-Pol-Env-Nef-Rev multiepitope construct and increased IFN-gamma secretion in infected lymphocytes
52-In Silico Design and Immunological Studies of Two Novel Multiepitope DNA-Based Vaccine Candidates Against High-Risk Human Papillomaviruses/2021 Dec;63(12):1192-1222. doi: 10.1007/s12033-021-00374-z. Epub 2021 Jul 25./https://link.springer.com/article/10.1007/s12033-021-00374-z
53-Combination of human papillomaviruses L1 and L2 multiepitope constructs protects mice against tumor cells/2021 Dec;35(6):1055-1068.doi: 10.1111/fcp.12690. Epub 2021 Jun 16./https://onlinelibrary.wiley.com/doi/10.1111/fcp.12690
دکتر کاظم باعثی
1-The Combinatorial Effect of Ad-IL-24 and Ad-HSV-tk/GCV on Tumor Size, Autophagy, and UPR Mechanisms in Multiple Myeloma Mouse Model/2025 Feb;63(1):315-330.doi: 10.1007/s10528-024-10671-2. Epub 2024 Mar 4./https://link.springer.com/article/10.1007/s10528-024-10671-2
5-The investigation of the death-inducing potency of a recombinant Adenovector expressing Mda-7-tlyp-1 on different cancer cell lines/2024;17(1):45-56./ doi: 10.22037/ghfbb.v17i1.2779./https://pmc.ncbi.nlm.nih.gov/articles/PMC11080692/
6-Heterologous DNA Prime/Protein Boost Immunization Targeting Nef-Tat Fusion Antigen Induces Potent T-cell Activity and in vitro Anti-SCR HIV-1 Effects/2024;22(2):109-119./ doi: 10.2174/011570162X297602240430142231./https://www.eurekaselect.com/article/140212
7-Inhibition of Mir-21-5p Affects the Expression of LNCRNA X-Inactive Specific Transcript and Induces Apoptosis in MCF-7 Breast Cancer Cells/Vol 53 No 3 (2024) /
8-A survey of resistance mutations to reverse transcriptase inhibitors (RTIs) among HIV-1 patients in northeast of Iran/2024;13(3):117-125./doi: 10.22099/mbrc.2024.48729.1895. /https://pmc.ncbi.nlm.nih.gov/articles/PMC11194027/
9-Interleukin-24-mediated antitumor effects against human glioblastoma via upregulation of P38 MAPK and endogenous TRAIL-induced apoptosis and LC3-II activation-dependent autophagy/ 2023 Jun 6;23(1):519./ doi: 10.1186/s12885-023-11021-y./https://pmc.ncbi.nlm.nih.gov/articles/PMC10242982/
10-Autophagy and unfolded protein response induction: a crosstalk between street rabies virus and the host/ 2023 Jul;28(4):423-428./doi: 10.1007/s12192-023-01335-y. Epub 2023 May 3./https://pmc.ncbi.nlm.nih.gov/articles/PMC10352205/
12-Drug-selective pressure effect on HIV integrase mutations in antiretroviral naïve and experienced patients//DOI: https://doi.org/10.5114/hivar.2023.127727 /2/2023 vol. 22/https://hivaids.termedia.pl/Drug-selective-pressure-effect-on-HIV-integrase-mutations-in-antiretroviral-naive,141632,0,2.html
13-Considering epitopes conservity in targeting SARS-CoV-2 mutations in variants: a novel immunoinformatics approach to vaccine design/
14-Corrigendum to "Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein" [Vaccine 40(20) (2022) 2856-2868]/2022 Nov 15;40(48):7009. doi: 10.1016/j.vaccine.2022.10.019. Epub 2022 Oct 28./
15-Corrigendum to "Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein" [Vaccine 40(20) (2022) 2856-2868]/2022 Nov 15;40(48):7009doi: 10.1016/j.vaccine.2022.10.019. Epub 2022 Oct 28. /https://pmc.ncbi.nlm.nih.gov/articles/PMC9613972/
17-Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein/2022 May 3;40(20):2856-2868./ doi: 10.1016/j.vaccine.2022.03.066. Epub 2022 Apr 4./https://pmc.ncbi.nlm.nih.gov/articles/PMC8977851/
19-Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein/2022 May 3;40(20):2856-2868./doi: 10.1016/j.vaccine.2022.03.066. Epub 2022 Apr 4./ https://pmc.ncbi.nlm.nih.gov/articles/PMC8977851/
20-Prevalence of Naturally Occurring Resistance Associated Substitutions in NS3/4AProtease Inhibitors in Iranian HCV/HIV Infected Patients/
23-HIV-1 Accessory Proteins: Which one is Potentially Effective in Diagnosis and Vaccine Development?/2021;28(6):687-698./doi: 10.2174/0929866528999201231213610. /https://www.eurekaselect.com/article/112924
25-Evaluation of HIV-1 Regulatory and Structural Proteins as Antigen Candidate in Mice and Humans/2021;19(3):225-237.doi: 10.2174/1570162X18999201125212131./https://www.eurekaselect.com/article/111854
26-Evaluation of HIV-1 Regulatory and Structural Proteins as Antigen Candidate in Mice and Humans/2021;19(3):225-237./doi: 10.2174/1570162X18999201125212131. /https://www.eurekaselect.com/article/111854
27-The Relationship Between HIV Antibody Titer, HIV Viral Load, HIV p24 Antigen, and CD4 T-cell Count Among Iranian HIV-positive Patients 2020;20(5):752-757./ doi: 10.2174/1871526519666191104144721./https://www.eurekaselect.com/article/102071
28-In vitro effect of branched polyethyleneimine (bPEI) on cells infected with human immunodeficiency virus: enhancement of viral replication/ 2019 Dec;164(12):3019-3026./doi: 10.1007/s00705-019-04426-3. Epub 2019 Oct 9./https://link.springer.com/article/10.1007/s00705-019-04426-3
34-There is no Difference Between Sequences of HIV-1 Infected Patients with Stable Clinical Status and HIV-1 Reference Sequence/ 2019;19(1):67-72./doi: 10.2174/1871526518666180222111611. /https://www.eurekaselect.com/article/88731
35-Preparation and Evaluation of Ribonuclease-Resistant Viral HIV RNA Standards Based on Armored RNA Technology/2018 Nov;22(6):394-400./doi: 10.29252/.22.6.394. Epub 2018 May 19./https://pmc.ncbi.nlm.nih.gov/articles/PMC6305816/
36-Design and Development of a Quantitative TaqMan Real-Time PCR Assay for Evaluation of HIV-1 (group M) Viral Load in Plasma Using Armored RNA Standard/
5-Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial/2024 Apr 8:15:1332425./doi: 10.3389/fimmu.2024.1332425. eCollection 2024./https://pmc.ncbi.nlm.nih.gov/articles/PMC11036872/
6-Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19/ 2023 Jun;18(9):563-574.
7-Impact of TRIM5α and TRIM22 Genes Expression on the Clinical Course of Coronavirus Disease 2019/2023 Feb;54(2):105-112./doi: 10.1016/j.arcmed.2022.12.010. Epub 2022 Dec 28.
9-Comparing the expression levels of tripartite motif containing 28 in mild and severe COVID-19 infection/2022 Oct 3;19(1):156.doi: 10.1186/s12985-022-01885-0. /https://pmc.ncbi.nlm.nih.gov/articles/PMC9527726/
10-Correction: comparing the expression levels of tripartite motif containing 28 in mild and severe COVID-19 infection/ 2022 Oct 31;19(1):171./ doi: 10.1186/s12985-022-01903-1./https://pmc.ncbi.nlm.nih.gov/articles/PMC9624030/
12-Label-Free Real-Time Detection of HBsAg Using a QCM Immunosensor/2022 Apr 1;68(4)./doi: 10.7754/Clin.Lab.2021.210537. /
13-Changes in the Distribution Pattern of Hepatitis C Virus Genotypes Among Chronic Hepatitis Patients: a Cross-Sectional Study2021 Aug 1;67(8)./doi: 10.7754/Clin.Lab.2021.201012. /https://www.clin-lab-publications.com/article/3849
14-The Effects of Human Reoviruses on Cancer Cells Derived from Hepatocellular Carcinoma Biopsies/ 2021 Mar 1;67(3)./doi: 10.7754/Clin.Lab.2020.200416. /https://www.clin-lab-publications.com/article/3683
15-Full-length Sequencing and Genotyping of Hepatitis A Virus among Acute Hepatic Patients in Iran/2021 May 1;67(5). doi: 10.7754/Clin.Lab.2020.200919./https://www.clin-lab-publications.com/article/3764
16-HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin/2016 Aug 23:6:31924.
17-HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages/2016 Feb 5;291(6):2696-711./ doi: 10.1074/jbc.M115.689018. Epub 2015 Dec 17./https://pmc.ncbi.nlm.nih.gov/articles/PMC4742738/
18-High frequency of human papillomavirus genotype 16 among patients with Anogenital warts/ 2015 Nov 21;8(11):e25882./doi: 10.5812/jjm.25882. eCollection 2015 Nov./https://pmc.ncbi.nlm.nih.gov/articles/PMC4740957/
19-Prevalence and distribution of BK virus subtypes in renal transplant recipients referred to Golestan hospital in Ahvaz, Iran/ 2015 Mar 21;8(3):e16738./doi: 10.5812/jjm.16738. eCollection 2015 Mar./https://pmc.ncbi.nlm.nih.gov/articles/PMC4385253/
20-Prevalence of rhinovirus and respiratory syncytial virus among patients with chronic rhinosinusitis/2015 Mar 21;8(3):e20068./doi: 10.5812/jjm.20068. eCollection 2015 Mar./https://pmc.ncbi.nlm.nih.gov/articles/PMC4386071/
21-Determination of cytomegalovirus prevalence and glycoprotein B genotypes among ulcerative colitis patients in Ahvaz, Iran/
24-Mutation analysis of hepatitis B virus reverse transcriptase region among untreated chronically infected patients in Ahvaz city (South-West of Iran)/